OncoDaily is Proud to Announce OncoDaily Grand Rounds: AI in Oncology Edition During ASCO 2026

OncoDaily is organizing the ASCO 2026 Grand Rounds: AI in Oncology Edition, with ZS serving as the exclusive partner. The session will focus on the expanding role of artificial intelligence in oncology and its implications for cancer care, research, and clinical practice. The event will take place during ASCO 2026 in Chicago.

Event Details

Date: May 30
Time: 5:00–8:00 PM
Location: Hyatt Regency McCormick Place Chicago 2233 S Martin Luther King Dr, Chicago, IL 60616, United States

Co-Chair

Images

Name

Douglas Flora MD, LSSBB, is board-certified medical oncologist, cancer survivor, and executive leader, he serves as Executive Medical Director of the Yung Family Cancer Center at St. Elizabeth Healthcare and Editor-in-Chief of AI in Precision Oncology. Author of Rebooting Cancer Care and President-Elect of the Association of Cancer Care Centers (ACCC), he is dedicated to advancing prevention, early detection, innovation, and equity across the cancer care continuum. As CEO of TensorBlack and a frequent keynote speaker, he champions the responsible integration of AI and emerging technologies to transform oncology while keeping compassionate, patient-centered care at the forefront.

Speakers

Images	Name
	Cristian Massacesi, MD, is Executive Vice President, Chief Medical Officer, and Head of Development at Bristol Myers Squibb, where he leads early- and late-stage product development across all therapeutic areas. A former medical oncologist with more than 20 years of global biopharmaceutical experience, he has held senior leadership roles at AstraZeneca, Alexion, Pfizer, and Novartis, advancing numerous clinical programs and regulatory approvals. He earned his medical degree from Marche Polytechnic University and completed oncology training at the Royal Marsden Hospital, Kaplan Comprehensive Cancer Center, and the European Institute of Oncology.
	Debra Patt is the Executive Vice President for Texas Oncology, leading public policy, academic affairs, and strategic initiatives. A breast cancer expert, she has led clinical trials in community practice since 2006. Board certified in medical oncology and clinical informatics, she drives research in AI, telemedicine, remote symptom monitoring, and digital health tools to improve cancer care. She serves as President of the Community Oncology Alliance, chairs ASCO’s AI Task Force, is a member of ASCO Board of Directors, guiding national efforts to advance oncology care.
	Pavankumar Anné is Head of ZS’s Precision Medicine and Oncology Practice and a seasoned life sciences leader with deep expertise across precision medicine, oncology, and specialty markets. He advises biopharma and diagnostics organizations on go-to-market strategy, pipeline and launch planning, growth marketing, customer engagement, and insights, with a strong track record of scaling high-performing teams. He holds an MBA from the Yale School of Management.
	Sanjay Juneja is a hematologist and medical oncologist and Vice President of Clinical AI Operations at Tempus, where he helps implement AI-enabled workflows in real-world cancer care with a focus on accuracy, equity, and clinician trust. Known online as @TheOncDoc to 750k+ learners, he is also Editor for the AI in Precision Oncology journal, co-founder of Medfluencers (acquired in 2026) and TensorBlack, and a published author dedicated to advancing AI-driven oncology.